Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Delcath Systems, Inc.    

DELCATH SYSTEMS, INC.
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsCalendarCompanyFinancials 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Company
Delcath Systems, Inc. is an oncology company, which focuses on the treatment of primary and metastatic liver cancers.It develops and commercializes Melphalan Hydrochloride for Injection, which is a proprietary product for use with the Delcath Hepatic Delivery System.The company was founded in... 
More about the company
Latest news on DELCATH SYSTEMS, INC.
06/08DELCATH SYSTEMS, INC. : Entry into a Material Definitive Agreement, Creation of ..
AQ
05/30DELCATH : to Present at the 8th Annual LD Micro Invitational
AQ
05/29DELCATH : to Present at the 8th Annual LD Micro Invitational
AQ
05/23DELCATH : Sponsors Looking For A Cure Ocular Melanoma Charity Event
AQ
05/17DELCATH : Delcaths CHEMOSAT Included in German Treatment Guidelines for Melanoma..
AQ
05/14DELCATH : PHP Therapy Featured in Video Learning Session at the European Confere..
PU
05/10DELCATH : Announces First Quarter 2018 Financial Results
AQ
05/10DELCATH : Management's Discussion and Analysis of Financial Condition and Result..
AQ
05/08DELCATH : Announces Initiation of Registrational Trial of Melphalan/HDS in Intra..
AQ
05/08DELCATH SYSTEMS, INC. : Delcath Systems, Technology Overview, Product Developmen..
AC
More news
Sector news : Medical Prosthetics
06/15Essilor Calls General Meeting for EssilorLuxottica
DJ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
06/12STRYKER : Approaches Rival Boston Scientific for Deal -- WSJ
DJ
More sector news : Medical Prosthetics
News from SeekingAlpha
06/12Delcath Systems announces rights offering 
06/05Delcath Systems (DCTH) Presents at 8th Annual LD Micro Invitational Conferenc.. 
05/10DELCATH SYSTEMS INC NEW reports Q1 results 
05/08YOUR DAILY PHARMA SCOOP : Synergy Activism, Pfizer Wave Sciences Collaboration, .. 
05/07Delcath launches pivotal study of Melphalan/HDS in type of liver caner 
Chart DELCATH SYSTEMS, INC.
Duration : Period :
Delcath Systems, Inc. Technical Analysis Chart | US24661P5008 | 4-Traders
Income Statement Evolution
Managers
NameTitle
Jennifer K. Simpson President, Chief Executive Officer & Director
Roger G. Stoll Chairman
John Purpura Executive Vice President-Global Operations
Barbra C. Keck Secretary, Chief Financial & Accounting Officer
William Dodge Rueckert Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DELCATH SYSTEMS, INC.-91.09%2
STRAUMANN HOLDING6.75%11 626
SONOVA HOLDING13.73%11 176
COCHLEAR LIMITED16.05%8 410
INSULET CORPORATION42.25%5 592
DENTIUM CO LTD--.--%895